CORCEPT THERAPEUTICS INC - Common Stock (CORT)

CUSIP: 218352102

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / Common Stock
Shares outstanding
105,274,735
Total 13F shares
45,723,356
Share change
+11,827,897
Total reported value
$249,638,429
Price per share
$5.46
Number of holders
109
Value change
+$64,877,791
Number of buys
66
Number of sells
35

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 218352102?
CUSIP 218352102 identifies CORT - CORCEPT THERAPEUTICS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CORT - CORCEPT THERAPEUTICS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FEDERATED HERMES, INC.
13F
Company
13%
14,189,245
$66,406,000 31 Mar 2016
13F
VANGUARD GROUP INC
13F
Company
2.6%
2,786,006
$13,039,000 31 Mar 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
2.4%
2,543,547
$11,904,000 31 Mar 2016
13F
MORGAN STANLEY
13F
Company
2%
2,110,093
$9,875,000 31 Mar 2016
13F
INVESTOR AB
13F
Company
1.7%
1,835,974
$8,592,000 31 Mar 2016
13F
BlackRock Fund Advisors
13F
Company
1.5%
1,613,004
$7,549,000 31 Mar 2016
13F
STATE STREET CORP
13F
Company
0.86%
902,240
$4,222,000 31 Mar 2016
13F
NORTHERN TRUST CORP
13F
Company
0.68%
714,414
$3,343,000 31 Mar 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.47%
494,148
$2,312,000 31 Mar 2016
13F
Brandywine Global Investment Management, LLC
13F
Company
0.39%
408,473
$1,912,000 31 Mar 2016
13F
THORNBURG INVESTMENT MANAGEMENT INC
13F
Company
0.38%
399,778
$1,871,000 31 Mar 2016
13F
First Eagle Investment Management, LLC
13F
Company
0.38%
395,670
$1,852,000 31 Mar 2016
13F
MENTA CAPITAL LLC
13F
Company
0.27%
282,030
$1,320,000 31 Mar 2016
13F
Bank of New York Mellon Corp
13F
Company
0.26%
271,065
$1,269,000 31 Mar 2016
13F
GLOBEFLEX CAPITAL L P
13F
Company
0.23%
244,483
$1,144,000 31 Mar 2016
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.23%
242,604
$1,135,000 31 Mar 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.21%
221,901
$1,038,000 31 Mar 2016
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.19%
200,733
$939,000 31 Mar 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.19%
199,453
$933,000 31 Mar 2016
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.18%
191,400
$896,000 31 Mar 2016
13F
Invesco Ltd.
13F
Company
0.18%
189,912
$889,000 31 Mar 2016
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.16%
163,987
$767,000 31 Mar 2016
13F
D.A. DAVIDSON & CO.
13F
Company
0.14%
147,685
$691,000 31 Mar 2016
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.14%
143,258
$670,000 31 Mar 2016
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.13%
140,000
$655,000 31 Mar 2016
13F
RUSSELL FRANK CO/
13F
Company
0.13%
132,596
$621,000 31 Mar 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.12%
131,064
$613,000 31 Mar 2016
13F
UBS Group AG
13F
Company
0.11%
112,388
$526,000 31 Mar 2016
13F
LPL Financial LLC
13F
Company
0.1%
105,000
$516,000 31 Mar 2016
13F
Swiss National Bank
13F
Company
0.1%
110,500
$500,000 31 Mar 2016
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.1%
104,895
$491,000 31 Mar 2016
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.1%
100,454
$470,000 31 Mar 2016
13F
GABELLI & Co INVESTMENT ADVISERS, INC.
13F
Company
0.09%
96,200
$450,000 31 Mar 2016
13F
TEACHERS ADVISORS, LLC
13F
Company
0.09%
90,023
$421,000 31 Mar 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.08%
86,506
$405,000 31 Mar 2016
13F
FALCON POINT CAPITAL, LLC
13F
Company
0.08%
86,006
$403,000 31 Mar 2016
13F
TFS CAPITAL LLC
13F
Company
0.08%
81,788
$383,000 31 Mar 2016
13F
Birchview Capital, LP
13F
Company
0.08%
80,000
$374,000 31 Mar 2016
13F
ANALYTIC INVESTORS, LLC
13F
Company
0.08%
79,581
$372,000 31 Mar 2016
13F
D. E. Shaw & Co., Inc.
13F
Company
0.07%
75,511
$353,000 31 Mar 2016
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.07%
74,200
$347,000 31 Mar 2016
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.06%
61,761
$290,000 31 Mar 2016
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.05%
57,457
$268,000 31 Mar 2016
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.05%
56,400
$264,000 31 Mar 2016
13F
CITIGROUP INC
13F
Company
0.05%
54,722
$256,000 31 Mar 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.05%
50,954
$238,000 31 Mar 2016
13F
METROPOLITAN LIFE INSURANCE CO/NY
13F
Company
0.05%
48,807
$228,000 31 Mar 2016
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
48,591
$227,000 31 Mar 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.04%
44,993
$211,000 31 Mar 2016
13F
Nationwide Fund Advisors
13F
Company
0.04%
41,361
$194,000 31 Mar 2016
13F

Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2016

As of 30 Jun 2016, CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,723,356 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, INGALLS & SNYDER LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., MORGAN STANLEY, BlackRock Fund Advisors, INVESTOR AB, Invesco Ltd., STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 109 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2016 vs Q1 2016 Across Filers

Q1 2016 holders
95
Q2 2016 holders
109
Holder diff
14
Investor Q1 2016 Shares Q2 2016 Shares Share Diff Share Chg % Q1 2016 Value $ Q2 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.